HK Stock MarketDetailed Quotes
01858 CHUNLI MEDICAL
- 8.490
- +0.330+4.04%
Market Closed Jul 5 16:08 CST
3.26BMarket Cap10.65P/E (TTM)
8.500High8.110Low453.50KVolume8.160Open8.160Pre Close3.76MTurnover0.48%Turnover Ratio10.63P/E (Static)383.57MShares14.74352wk High1.01P/B807.74MFloat Cap7.92352wk Low0.40Dividend TTM95.14MShs Float62.109Historical High0.397Dividend LFY4.78%Amplitude0.371Historical Low8.292Avg Price250Lot Size4.68%Div YieldTTM4.68%Div Yield LFY
CHUNLI MEDICAL Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.95%221.85M | 0.58%1.21B | 4.24%792.16M | -5.37%540.71M | -4.18%246.36M | 8.43%1.2B | 5.79%759.96M | 18.39%571.39M | 13.45%257.11M | 18.18%1.11B |
| Operating income | -9.95%221.85M | 0.58%1.21B | 4.24%792.16M | -5.37%540.71M | -4.18%246.36M | 8.43%1.2B | 5.79%759.96M | 18.39%571.39M | 13.45%257.11M | 18.18%1.11B |
| Operating expenses | 25.51%-58.04M | -15.47%-332.64M | -17.08%-232.37M | -2.55%-149.3M | -55.17%-77.92M | -13.60%-288.08M | -18.58%-198.48M | -28.42%-145.59M | 11.35%-50.21M | 1.30%-253.6M |
| Gross profit | -2.75%163.81M | -4.12%875.89M | -0.30%559.78M | -8.08%391.41M | -18.59%168.44M | 6.90%913.53M | 1.90%561.49M | 15.31%425.8M | 21.72%206.9M | 25.53%854.54M |
| Selling expenses | 2.80%-63.15M | 2.13%-383.14M | -1.56%-233.75M | -7.66%-166.89M | 18.69%-64.97M | -14.45%-391.47M | 1.55%-230.17M | -8.68%-155.01M | -24.04%-79.9M | -41.92%-342.05M |
| Administrative expenses | -6.69%-7.52M | -14.50%-44.47M | -17.15%-28.91M | -22.59%-18.96M | -17.28%-7.05M | -26.63%-38.84M | -15.36%-24.68M | -13.54%-15.46M | -8.06%-6.01M | 1.76%-30.67M |
| Research and development expenses | -5.17%-34.99M | 3.02%-157.45M | -9.26%-114.74M | -3.16%-74.57M | -0.47%-33.27M | -54.84%-162.34M | -61.11%-105.01M | -111.19%-72.29M | -124.70%-33.11M | -44.41%-104.84M |
| Profit from asset sales | ---- | -84.57%3.9K | -102.17%-549.43 | ---- | ---- | 70.33%25.31K | 70.33%25.31K | 208.84%25.31K | 208.84%25.31K | 109.39%14.86K |
| Revaluation surplus | -31.73%1.38M | 1.27%9.61M | 8.14%7.07M | 10.60%4.38M | 19.29%2.02M | --9.49M | --6.54M | --3.96M | --1.7M | ---- |
| -Changes in the fair value of other assets | -31.73%1.38M | 1.27%9.61M | 8.14%7.07M | 10.60%4.38M | 19.29%2.02M | --9.49M | --6.54M | --3.96M | --1.7M | ---- |
| Impairment and provision | 31.10%-5.48M | 17.33%-25.02M | 14.50%-11.48M | 28.70%-11.96M | -58.09%-7.95M | -10.91%-30.27M | -4.13%-13.43M | -63.90%-16.78M | 16.95%-5.03M | -338.47%-27.29M |
| -Other impairment is provision | 31.10%-5.48M | 17.33%-25.02M | 14.50%-11.48M | 28.70%-11.96M | -58.09%-7.95M | -10.91%-30.27M | -4.13%-13.43M | -63.90%-16.78M | 16.95%-5.03M | -338.47%-27.29M |
| Special items of operating profit | 10.49%6.02M | 13.14%24.82M | -47.15%15.19M | 128.98%14.08M | 567.34%5.45M | 25.68%21.94M | 85.95%28.73M | -54.22%6.15M | -28.20%816.85K | 108.45%17.45M |
| Operating profit | -4.75%58.24M | -6.26%289.39M | -12.73%187.42M | -20.96%133.47M | -26.22%61.14M | -13.75%308.73M | -5.28%214.75M | -4.64%168.86M | 5.32%82.87M | 8.98%357.95M |
| Financing cost | -9.55%1.08M | -17.81%16.58M | -48.62%8.52M | -13.57%4.99M | -14.82%1.2M | 109.24%20.17M | 94.68%16.58M | 8.00%5.78M | -63.31%1.41M | 489.13%9.64M |
| Special items of earning before tax | 819.68%839.1K | -100.87%-69.6K | 97.78%-49.92K | 103.46%77.61K | 91.23%-116.59K | 3,843.45%7.97M | -1,295.24%-2.25M | -1,126.43%-2.24M | -895.46%-1.33M | 14.47%-212.93K |
| Earning before tax | -3.31%60.16M | -9.19%305.91M | -14.49%195.88M | -19.64%138.54M | -24.99%62.23M | -8.30%336.88M | -2.55%229.07M | -5.41%172.4M | 0.68%82.95M | 11.38%367.38M |
| Tax | 20.53%-5.06M | 3.68%-28.09M | 20.47%-15.4M | 18.57%-12.55M | 28.73%-6.36M | 35.22%-29.16M | 37.32%-19.37M | 42.26%-15.41M | 35.79%-8.93M | 3.13%-45.02M |
| After-tax profit from continuing operations | -1.35%55.11M | -9.72%277.82M | -13.94%180.48M | -19.75%125.99M | -24.53%55.86M | -4.54%307.72M | 2.71%209.71M | 0.92%156.98M | 8.09%74.02M | 13.76%322.36M |
| Earning after tax | -1.35%55.11M | -9.72%277.82M | -13.94%180.48M | -19.75%125.99M | -24.53%55.86M | -4.54%307.72M | 2.71%209.71M | 0.92%156.98M | 8.09%74.02M | 13.76%322.36M |
| Minority profit | ---92.55K | ---5.9K | ---142.39K | ---91.88K | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -1.18%55.2M | -9.72%277.82M | -13.87%180.62M | -19.69%126.08M | -24.53%55.86M | -4.54%307.72M | 2.71%209.71M | 0.92%156.98M | 8.09%74.02M | 13.76%322.36M |
| Basic earnings per share | -6.67%0.14 | -10.00%0.72 | -14.55%0.47 | -19.51%0.33 | -21.05%0.15 | -13.98%0.8 | -6.78%0.55 | -8.89%0.41 | -5.00%0.19 | 13.41%0.93 |
| Diluted earnings per share | -6.67%0.14 | -10.00%0.72 | -14.55%0.47 | -19.51%0.33 | -21.05%0.15 | -13.98%0.8 | -6.78%0.55 | -8.89%0.41 | -5.00%0.19 | 13.41%0.93 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg